sales@businessmarketinsights.com     UK: +442081254005
   

South and Central America Nasal Delivery Devices Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Drug Type (Anaesthetics, Antibiotics, Pain Relief Drugs, Calcium Supplements, Vasoconstrictors, Antihistamines, and Others); Delivery Technologies (Spray, Nebulizers, Inhalers, and Others); End User (Home Care Settings, Hospitals, and Clinics); and Country

Code: TIPRE00018201 | Pages: 125 | Industry: Medical Device | Date: Jan 2021
Covid

Market Introduction

Drug delivery systems are the technologies primarily used for the controlled or targeted delivery of various therapeutic agents to treat various diseases or improve the health of the patients. Nasal drug delivery is one of the efficient routes of drug administration. It offers needle-free drug delivery, optimal route for brain-targeted therapies, and superior bioavailability. Nasal route of administration is preferred in several disease indications such as Parkinson’s disease, prostate cancer, migraine, and influenza amongst others. Moreover, nasal route is also suitable for the treatment of drug addiction as well as for sedation.

 

Market Overview and Dynamics

The South and Central America nasal delivery devices market is expected to reach US$ 7,548.89 million in 2027 from US$ 4,916.69 million in 2019. The market is estimated to grow with a CAGR of 5.6% from 2020-2027. The growth of the market is attributed to some key driving factors such as the increasing geriatric population across South and Central America and the growing burden of non-communicable diseases. However, the market growth is likely to be hindered owing to the concerns related to the administration of the nasal delivery medications.

 

Key Market Segments

Based on drug type, the nasal delivery devices market is anaesthetics, antibiotics, pain relief drugs, calcium supplements, vasoconstrictors, antihistamines, and others. Based on delivery technologies, the nasal delivery devices market, is segmented into spray, nebulizers, inhalers, and others. Based on end user, the nasal delivery devices market, is segmented into home care settings, hospitals, and clinics.

 

Major Sources and Companies Listed

Some of the major primary and secondary sources for nasal delivery devices market included in the report are Brazil Statistical Institute, GLOBOCAN, and others.

Reasons to buy the report

  • To understand the South and Central America nasal delivery devices market landscape and identify market segments that are most likely to guarantee a strong return
  • Stay ahead of the race by comprehending the ever-changing competitive landscape for nasal delivery devices market
  • Efficiently plan M&A and partnership deals in South and Central America nasal delivery devices market by identifying market segments with the most promising probable sales
  • Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Nasal delivery devices market
  • Obtain market revenue forecast for market by various segments from 2019 to 2027 in South and Central America region

 

SOUTH AND CENTRAL AMERICA NASAL DELIVERY DEVICES MARKET SEGMENTATION

 

By Drug Type

  • Anaesthetics
  • Antibiotics
  • Pain Relief Drugs
  • Calcium Supplements
  • Vasoconstrictors
  • Antihistamines
  • Others

 

By Delivery Technologies

  • Spray
  • Nebulizers
  • Inhalers
  • Others

 

By End User

  • Home Care Settings
  • Hospitals
  • Clinics

 

By Country

  • South and Central America
    • Brazil
    • Argentina
    • Rest of South and Central America

 

Company Profiles

  • GlaxoSmithKline plc.
  • AstraZeneca
  • Pfizer Inc.
  • BD
  • Sanofi
  • Merck & Co., Inc.
  • Cadila Pharmaceuticals Ltd.
  • Novartis AG
 

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Nasal Delivery Devices Market – By Drug Type

1.3.2        Nasal Delivery Devices Market – By Delivery Technologies

1.3.3        Nasal Delivery Devices Market – By End User

1.3.4        South and Central America nasal Delivery Devices Market – By Country

2.           South and Central America nasal Delivery Devices Market – Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           South and Central America nasal Delivery Devices Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Nasal Delivery Devices Market- South and Central America PEST Analysis

4.3         Expert Opinion

5.           South and Central America nasal Delivery Devices Market - Key Market Dynamics

5.1         Market Drivers

5.1.1        Increasing Geriatric Population across South and Central America

5.1.2        Growing Burden of Non-Communicable Diseases

5.2         Market Restraints

5.2.1        Concerns Related to the Administration of the Nasal Delivery Medications

5.3         Market Opportunities

5.3.1        High Growth in Public Awareness Regarding Nasal Drug Delivery and its Self-Administration

5.4         Future Trends

5.4.1        Increasing Involvement of Public-Private Organizations

5.5         Impact Analysis

6.           Nasal Delivery Devices Market – South and Central America Analysis

6.1         South and Central America nasal Delivery Devices Market Revenue Forecasts and Analysis

7.           South and Central America nasal Delivery Devices Market Analysis and Forecasts To 2027 – By Drug Type

7.1         Overview

7.2         Nasal Delivery Devices Market Revenue Share, by Drug Type(2019 and 2027)

7.3         Anaesthetics

7.3.1        Overview

7.3.2        Anaesthetics: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

7.4         Antibiotics

7.4.1        Overview

7.4.2        Antibiotics: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

7.5         Pain Relief Drugs

7.5.1        Overview

7.5.2        Pain Relief Drugs: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

7.6         Calcium Supplements

7.6.1        Overview

7.6.2        Calcium Supplements: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

7.7         Vasoconstrictors

7.7.1        Overview

7.7.2        Vasoconstrictors: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

7.8         Antihistamines

7.8.1        Overview

7.8.2        Antihistamines: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

7.9         Others

7.9.1        Overview

7.9.2        Others: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

8.           South and Central America nasal Delivery Devices Market Analysis – By Delivery Technologies

8.1         Overview

8.2         Nasal Delivery Devices Market Revenue Share, by Delivery Technologies (2019 and 2027)

8.3         Spray

8.3.1        Overview

8.3.2        Spray: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

8.4         Nebulizers

8.4.1        Overview

8.4.2        Nebulizer: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

8.5         Inhalers

8.5.1        Overview

8.5.2        Inhalers: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

8.6         Others

8.6.1        Overview

8.6.2        Others: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

9.           South and Central America nasal Delivery Devices Market Analysis – By End-User

9.1         Overview

9.2         Nasal Delivery Devices Market Revenue Share, by End -User(2019 and 2027)

9.3         Home Care Settings

9.3.1        Overview

9.3.2        Home Care Settings: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

9.4         Hospitals

9.4.1        Overview

9.4.2        Hospitals: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

9.5         Clinics

9.5.1        Overview

9.5.2        Clinics: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

10.        Nasal Delivery Devices Market Revenue and Forecasts To 2027 – Geographical Analysis

10.1      South and Central America: Nasal Delivery Devices Market

10.1.1     Overview

10.1.2     South and Central America: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)

10.1.3     South and Central America Nasal Delivery Devices Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

10.1.4     South and Central America Nasal Delivery Devices Market, by Delivery Technologies – Revenue and Forecast to 2027 (USD Million)

10.1.5     South and Central America Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.1.6     South and Central America: Nasal Delivery Devices Market, by Country, 2019 & 2027 (%)

10.1.7     Brazil: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.1       Brazil: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.2       Brazil Nasal Delivery Devices Market, by Drug Type– Revenue and Forecast to 2027 (USD Million)

10.1.7.3       Brazil Nasal Delivery Devices Market, by Delivery Technologies – Revenue and Forecast to 2027 (USD Million)

10.1.7.4       Brazil Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.1.8     Argentina: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.1       Argentina: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.2       Argentina Nasal Delivery Devices Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

10.1.8.3       Argentina Nasal Delivery Devices Market, by Delivery Technologies – Revenue and Forecast to 2027 (USD Million)

10.1.8.4       Argentina Nasal Delivery Devices Market, by Mode – Revenue and Forecast to 2027 (USD Million)

10.1.9     Rest of South and Central America: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.1       Rest of South and Central America: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.2       Rest of South and Central America nasal Delivery Devices Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

10.1.9.3       Rest of South and Central America nasal Delivery Devices Market, by Delivery Technologies– Revenue and Forecast to 2027 (USD Million)

10.1.9.4       Rest of South and Central America nasal Delivery Devices Market, by End-User– Revenue and Forecast to 2027 (USD Million)

11.        Impact of COVID-19 Pandemic on South and Central America nasal Delivery Devices Market

11.1      South and Central America: Impact Assessment of COVID-19 Pandemic

12.        COMPANY PROFILES

12.1      Sanofi

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      GlaxoSmithKline plc.

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      AstraZeneca

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      Pfizer Inc.

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

13.        Appendix

13.1      About the Insight Partners

13.2      Glossary of terms

LIST OF TABLES

Table 1.             South and Central America Nasal Delivery Devices Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

Table 2.             South and Central America Nasal Delivery Devices Market, by Delivery Technologies – Revenue and Forecast to 2027 (USD Million)

Table 3.             South and Central America Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 4.             Brazil Nasal Delivery Devices Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

Table 5.             Brazil Nasal Delivery Devices Market, by Delivery Technologies – Revenue and Forecast to 2027 (USD Million)

Table 6.             Brazil Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 7.             Argentina Nasal Delivery Devices Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

Table 8.             Argentina Nasal Delivery Devices Market, by Delivery Technologies – Revenue and Forecast to 2027 (USD Million)

Table 9.             Argentina Nasal Delivery Devices Market, by Mode – Revenue and Forecast to 2027 (USD Million)

Table 10.          Rest of South and Central America Nasal Delivery Devices Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

Table 11.          Rest of South and Central America Nasal Delivery Devices Market, by Delivery Technologies – Revenue and Forecast to 2027 (USD Million)

Table 12.          Rest of South and Central America Nasal Delivery Devices Market, by End-User – Revenue and Forecast to 2027 (USD Million)

Table 13.          Glossary of Terms, Nasal Delivery Devices Market

 

LIST OF FIGURES

Figure 1.           Nasal Delivery Devices market Segmentation

Figure 2.           South and Central America nasal Delivery Devices Market Overview

Figure 3.           Home Care Settings Segment Held Largest Share of End User in Nasal Delivery Devices market

Figure 4.           Brazil is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.           Nasal Delivery Devices Market - South and Central America PEST Analysis

Figure 6.           Nasal Delivery Devices Market Impact Analysis of Driver and Restraints

Figure 7.           South and Central America nasal Delivery Devices Market – Revenue Forecasts and Analysis – 2019- 2027

Figure 8.           Nasal Delivery Devices Market Revenue Share, by Drug Type (2019 and 2027)

Figure 9.           Anaesthetics: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

Figure 10.        Antibiotics: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

Figure 11.        Pain Relief Drugs: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

Figure 12.        Calcium Supplements: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

Figure 13.        Vasoconstrictors: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

Figure 14.        Antihistamines: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

Figure 15.        Others: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

Figure 16.        Nasal Delivery Devices Market Revenue Share, by Delivery Technologies (2019 and 2027)

Figure 17.        Spray: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

Figure 18.        Nebulizer: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

Figure 19.        Inhalers: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

Figure 20.        Others: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

Figure 21.        Nasal Delivery Devices Market Revenue Share, by End -User (2019 and 2027)

Figure 22.        Home Care Settings: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

Figure 23.        Hospitals: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

Figure 24.        Clinics: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

Figure 25.        South and Central America: Nasal Delivery Devices Market, by Key Country – Revenue (2019) (USD Million)

Figure 26.        South and Central America Nasal Delivery Devices Market Revenue and Forecast to 2027 (USD Million)

Figure 27.        South and Central America: Nasal Delivery Devices Market, by Country, 2019 & 2027 (%)

Figure 28.        Brazil: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)

Figure 29.        Argentina: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)

Figure 30.        Rest of South and Central America: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)

Figure 31.        Impact of COVID-19 Pandemic in South and Central America Country Markets

 

  1. GlaxoSmithKline plc.
  2. AstraZeneca
  3. Pfizer Inc.
  4. BD
  5. Sanofi
  6. Merck & Co., Inc.
  7. Cadila Pharmaceuticals Ltd.
  8. Novartis AG
  • To understand the South and Central America nasal delivery devices market landscape and identify market segments that are most likely to guarantee a strong return
  • Stay ahead of the race by comprehending the ever-changing competitive landscape for nasal delivery devices market
  • Efficiently plan M&A and partnership deals in South and Central America nasal delivery devices market by identifying market segments with the most promising probable sales
  • Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Nasal delivery devices market
  • Obtain market revenue forecast for market by various segments from 2019 to 2027 in South and Central America region

Related Tags South and Central America Nasal Delivery Devices Market South and Central America Nasal Delivery Devices Market Research South and Central America Nasal Delivery Devices Market Insight South and Central America Nasal Delivery Devices Market Trends South and Central America Nasal Delivery Devices Market Forecast South and Central America Nasal Delivery Devices Market Share South and Central America Nasal Delivery Devices Market 2027 South and Central America Nasal Delivery Devices Market Growth South and Central America Nasal Delivery Devices Industry Sector South and Central America Nasal Delivery Devices PDF Report South and Central America Nasal Delivery Devices Analysis South and Central America Nasal Delivery Devices Research Competitive Analysis

Purchase Options
Single User License
$3000
Site License
$4000
Enterprise License
$5000